Clay Thorp is Director & 10% Owner at Clearside Biomedical, Inc. (CLSD). They have made 29 open-market trades across 3 companies since 2016, most recently 2025-02-24.
CIK 0001592380
12 open-market purchases totalling $11.0M since 2016, against 17 sales. Across 12 scored buys the stock is up 3.7% at ninety days, and 2.1 points ahead of the S&P over the same stretch.
12 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 67% | 25% | 42% |
| Avg Move | +6.9% | -4.6% | +3.7% |
| Alpha | +8.3% | -1.4% | +2.1% |
| Scored | 12 | 12 | 12 |
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 56% | 56% | 56% |
| Avg Move | -3.0% | -4.7% | -0.7% |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CLSD | BUY | 2025-02-24 | 2025-02-24 | $0.92 | $14K | +13.2% | +18.3% | -4.9% |
| CLSD | BUY | 2023-09-25 | 2023-09-25 | $0.86 | $9K | +4.0% | -15.5% | +35.3% |
| CLSD | BUY | 2022-12-21 | 2022-12-21 | $1.02 | $14K | +48.0% | +50.0% | +2.0% |
| VIGL | BUY | 2022-05-16 | 2022-05-17 | $2.81 | $165K | -12.5% | -23.5% | +136.6% |
| VIGL | BUY | 2022-03-28 | 2022-03-28 | $7.20 | $22K | -6.4% | -34.4% | -55.3% |
| VIGL | BUY | 2022-01-11 | 2022-01-11 | $14.00 | $3.7M | +12.9% | +25.2% | -46.6% |
| PHAS | BUY | 2021-08-18 | 2021-08-18 | $3.00 | $30K | +5.5% | -5.9% | -3.9% |
| CLSD | SELL | 2021-02-10 | 2021-02-12 | $4.43 | $291K | -15.6% | -18.7% | -39.7% |
| PHAS | BUY | 2020-11-23 | 2020-11-24 | $3.60 | $18K | +21.6% | -0.3% | +20.2% |
| PHAS | SELL | 2019-07-01 | 2019-07-03 | $14.00 | $41K | -21.3% | -43.6% | -71.5% |
| PHAS | SELL · 10b5-1 | 2019-06-18 | 2019-06-20 | $14.00 | $6K | +15.7% | -17.5% | -58.4% |
| CLSD | BUY | 2018-12-06 | 2018-12-06 | $1.36 | $11K | -7.8% | -15.6% | -2.1% |
| PHAS | BUY | 2018-12-04 | 2018-12-06 | $3.13 | $13K | +5.9% | -9.5% | -22.2% |
| PHAS | BUY | 2018-10-22 | 2018-10-24 | $5.00 | $1.5M | -3.0% | -41.5% | -30.5% |
| CLSD | SELL | 2018-05-17 | 2018-05-21 | $13.10 | $2.9M | -25.9% | -18.4% | -49.8% |
| CLSD | SELL | 2018-03-21 | 2018-03-23 | $12.18 | $2.2M | -12.9% | -5.3% | -12.8% |
| CLSD | SELL | 2017-12-05 | 2017-12-07 | $6.22 | $218K | -7.4% | +11.2% | +128.8% |
| CLSD | SELL | 2017-11-14 | 2017-11-16 | $7.00 | $245K | +2.6% | -12.3% | -15.1% |
| CLSD | SELL | 2017-10-03 | 2017-10-05 | $8.59 | $430K | -8.1% | -16.7% | -16.7% |
| CLSD | SELL | 2017-09-13 | 2017-09-15 | $7.52 | $184K | +13.5% | +3.2% | -21.1% |
| CLSD | SELL | 2017-08-07 | 2017-08-09 | $7.57 | $185K | -2.7% | +10.8% | +8.2% |
| CLSD | SELL | 2017-05-18 | 2017-05-19 | $8.34 | $325K | -10.7% | +2.5% | -12.3% |
| CLSD | SELL | 2017-05-15 | 2017-05-17 | $8.70 | $609K | -16.3% | -7.1% | -17.9% |
| CLSD | SELL | 2017-04-17 | 2017-04-19 | $7.47 | $843K | +10.0% | +8.2% | +31.5% |
| CLSD | SELL | 2017-03-15 | 2017-03-17 | $6.61 | $595K | +13.2% | +7.5% | +11.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| Scored | 16 | 16 | 16 |